[1]
“Design Strategy and In-Silico Investigation of Indole-Functionalized Isoxazoles as Potential Antiparkinsonism Activity”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/r8r8je74.